This site is no longer actively maintained. It remains posted for archive purposes only.

Please see the new Division of Emerging Infections and Surveillance Services (DEISS) site.

Selected Accomplishments of the EIP Network

• Foodborne pathogens cause an estimated 76 million illnesses, 325,000 hospitalizations, and 5,000 deaths in the United States each year. EIP/FoodNet data documented recent declines in major bacterial foodborne illnesses, including infections caused by Yersinia, Listeria, Campylobacter, and Salmonella, at FoodNet sites (see MMWR 2002;51 (15):325-329).
  
  
• Since its emergence in the 1970s, group B streptococcus (GBS) disease has been the leading invasive bacterial infection associated with illness and death among newborns in the United States. Data developed through the EIP/ABCs provided a basis for revisions to recommendations for the prevention of perinatal group B streptococcal disease. Universal screening is now recommended. (see MMWR Recommendations and Reports 2002;51 (RR-11):1-22).
  
  
• The EIP Unexplained Deaths and Critical Illnesses project has developed methods for evaluating severe syndromes indicating infection. This enhanced syndrome-based surveillance approach holds potential for improving laboratory diagnostics.
  
  
• The EIP maintains sufficient flexibility for emergency response capacity and is able to address new problems as they arise:
  • In 1996 a rapid survey of neurologists, neuropathologists, and pathologists and a review of death certificate data at EIP sites provided some assurance that variant Creutzfeld Jacob Disease (vCJD) was not occurring in EIP states (see MMWR 1996; 45(31):665-668).
    
    
  • EIP resources are routinely used to facilitate infectious disease outbreak investigations (see Jones et al. An Outbreak of Community-Acquired Foodborne Illness Caused by Methicillin-Resistant Staphylococcus aureus. Emerg Infect Dis 2002; 8(1):82-84.)
    
    
• ABCs established definitive ranges for the age- and serotype-specific incidence of invasive pneumococcal disease, which contributed to the Advisory Committee on Immunization Practice's recommendations regarding the future use of a pneumococcal conjugate vaccine in children.
  
  
• The burden of chronic liver disease (of both viral and nonviral etiology) in well-defined populations was found to be significantly higher than previously reported. The estimated incidence of newly-diagnosed liver disease was 31/100,000 in 1998, a figure nearly three times the rate found when it was last measured in 1989.